Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Pediatric Infect Dis Soc ; 11(6): 300-302, 2022 Jun 22.
Article in English | MEDLINE | ID: mdl-35395086

ABSTRACT

We reviewed autopsy data from general hospitals in Lviv, Ukraine to understand pediatric mortality due to tuberculosis (TB). We identified 14 (0.6%) of 2345 autopsied children with unrecognized or untreated TB. More sensitive TB diagnostics for children and improved strategies for identifying which children require TB evaluation are urgently needed.


Subject(s)
Hospitals, General , Tuberculosis , Autopsy , Child , Humans , Tuberculosis/diagnosis , Tuberculosis/epidemiology , Ukraine/epidemiology
2.
J Epidemiol Glob Health ; 9(1): 56-61, 2019 03.
Article in English | MEDLINE | ID: mdl-30932391

ABSTRACT

Few reports have described pediatric Multidrug-resistant Tuberculosis (MDR-TB) in the former Soviet republics, despite the fact that these countries have the highest proportion of TB cases that are MDR. We aimed to examine pediatric MDR-TB in Ukraine. This retrospective cohort study included all children <18 years of age who started undergoing MDR-TB treatment between January 1, 2011 and July 31, 2016 at Kyiv City Pediatric TB Hospital. From each child's clinical chart, we abstracted demographic and clinical data. Using Fisher's exact test, we compared characteristics between children with microbiologically confirmed vs. probable (i.e., clinically diagnosed) MDR-TB. The study population included 20 children with a median age of 5 years. At diagnosis, 12 (60%) had intrathoracic lymphadenopathy as their only radiographic abnormality, and two (10%) were asymptomatic. Children with confirmed MDR-TB were more likely to be adolescents or have radiologic abnormalities in addition to intrathoracic lymphadenopathy. Median treatment duration was 20 months. Eighteen (90%) children were treated successfully. The remaining two were transferred to another facility, and their final outcomes were unknown. The excellent outcomes in this cohort are consistent with high treatment success rates for pediatric MDR-TB reported in other parts of the world.


Subject(s)
Tuberculosis, Multidrug-Resistant/epidemiology , Adolescent , Antitubercular Agents/therapeutic use , Child , Child, Preschool , Female , Humans , Male , Mycobacterium tuberculosis/drug effects , Retrospective Studies , Ukraine/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...